The usual observed standard treatment for sarcoidosis includes steroids with MTX and AZA as first line steroid-sparing agents; anti-TNF inhibitors are used for patients with contraindications to these treatments or with severe or refractory disease (1, 2, 11). Here, TNF is linked to sarcoidosis.